Privia Health Group, Inc. has announced its financial results for the third quarter of 2026, demonstrating robust growth and raising its full-year guidance. The company reported a net income of $25.6 million for the year-to-date period, marking an impressive 85.9% increase compared to the same period last year. Additionally, Privia's adjusted EBITDA reached $114.7 million, reflecting a 21.9% growth year-over-year.
This update is significant not only for Privia Health Group but also for the broader health services industry, as companies strive to enhance their operational efficiencies and expand their market presence. The results indicate that Privia is effectively navigating the competitive landscape, which includes established players and new entrants in the health services sector.
Background
Privia Health Group, Inc. is a prominent player in the health services industry, classified under the Standard Industrial Classification (SIC) code 8000. The company operates as a large accelerated filer and trades on the Nasdaq under the ticker symbol PRVA. Privia Health is headquartered in Arlington, Virginia, and focuses on delivering value-based care solutions.
What the Filing Says
According to the recent SEC filing (accession number 0001759655-26-000083), Privia Health issued a press release detailing its financial results for the third quarter ended September 30, 2026. The filing states, "YTD’26 Net Income of $25.6M, +85.9% from YTD’25" and "YTD’26 Adjusted EBITDA of $114.7M, +21.9% from YTD’25." The company also raised its full-year 2026 guidance to above the high end for all key financial metrics.
Impact
The strong financial performance reported by Privia Health Group may have significant implications for its stakeholders, including investors, employees, and healthcare partners. The increase in net income and adjusted EBITDA signals effective management and operational efficiency, which can enhance investor confidence and attract new partnerships. Additionally, competitors in the health services sector will likely analyze Privia's strategies and results as they plan their own growth initiatives.
What's Next
The filing does not specify what happens next for Privia Health Group. However, the raised guidance suggests that the company is poised for continued growth and may pursue further strategic initiatives in the near future.
Read Next
Trulieve reports Q3 2026 results, highlights growth strategies
National Grid reports strong half-year results, boosts investment
Enovis Corp Reports Q3 Results, Highlights Growth Strategies
NexPoint Real Estate Finance reports financial results
Cognition Therapeutics reports Q3 2026 financial results
Walker & Dunlop reports strong Q3 results, boosts outlook






